Official UK procurement notice
Contract for Remdesivir · UK public procurement notice
Authority: Northern Health and Social Care Trust (Central government)
What is being bought
Published requirement descriptionContract for supply of Remdesivir Powder for infusion
CPV: Pharmaceutical products
The lotProcurement structure
single lot · no lot value publishedLot #1Contract for supply of Remdesivir Powder for infusion for maximum of 12 months
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- Price
Procedure terms & legal framework
From the official record- Procedure method
- Negotiated without publication of a contract notice
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 30 Jan 2024, 16:25 GMT
- Last source update
- 30 Jan 2024, 16:25 GMT
- Authority reference
DAC74/1223PM- FTS notice number
2024/S 000-003118- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0435d3Find a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights
- Published justification
Regulation 32(2)(b)iii permits the award of a public contract by a negotiated procedure without prior publication where the works, supplies or services can only be supplied by a particular economic operator due to the protection of exclusive rights, including intellectual property rights. The absence of competition is not the result of an artificial narrowing down of the parameters of the procurement.
The Northern Trust requires the purchase of Remdesivir injection which is subject to patent protection / Sole MA Holder and consequently no reasonable alternative of substitute exists.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Gilead Sciences Ltd | £100,000 † | — | Awarded |
Contracts
Contract 003118-2024-DAC74/1223PM-1 · Gilead Sciences Ltd
- Signed
- 1 Dec 2023
- Value
- £100,000
- Status
- active
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- Gilead Sciences LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.